FDA approves DengvaxiaŽ for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas

Thursday, May 2, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Media Relations ContactNicolas KressmannTel.: +1 732-532-5318Nicolas.Kressmann@Sanofi.com

Investor Relations ContactGeorge GrofikTel.: +33 (0)1 53 77 45 45ir@sanofi.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store